1. Home
  2. GSAT vs TMDX Comparison

GSAT vs TMDX Comparison

Compare GSAT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$68.44

Market Cap

7.5B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.41

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSAT
TMDX
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
3.9B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
GSAT
TMDX
Price
$68.44
$136.41
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$52.75
$133.00
AVG Volume (30 Days)
1.0M
835.5K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.70
EPS
N/A
2.54
Revenue
$262,202,000.00
$566,354,000.00
Revenue This Year
$10.89
$38.84
Revenue Next Year
$10.07
$20.43
P/E Ratio
N/A
$53.83
Revenue Growth
8.54
41.20
52 Week Low
$17.24
$55.00
52 Week High
$70.83
$156.00

Technical Indicators

Market Signals
Indicator
GSAT
TMDX
Relative Strength Index (RSI) 71.09 54.31
Support Level $58.02 $133.50
Resistance Level $62.68 $156.00
Average True Range (ATR) 3.73 8.50
MACD 0.30 0.41
Stochastic Oscillator 85.91 55.98

Price Performance

Historical Comparison
GSAT
TMDX

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: